A century ago, patients were treated with insulins from pigs and cattle. Today, patients have access to insulins that operate at the molecular level which more closely resemble insulin released naturally in the body, and more effectively manage the disease. The options available today also help meet a wide range of unmet needs, providing patients with the tools necessary to stay adherent and healthy – saving costs throughout the health care system. However, this innovation isn’t enough if patients can’t afford their insulin and other medicines at the pharmacy.